Source: Annual Congress 2012 - New ATS/ERS recommendations for bronchoprovocation challenge testing



Rating:

Share or cite this content

Citations should be made in the following way:
J.D. Leuppi (Basel, Switzerland). Mannitol: a new development in challenge testing. Annual Congress 2012 - New ATS/ERS recommendations for bronchoprovocation challenge testing

Member's Comments

No comment yet.

Related content which might interest you: Novel capsaicin challenge methodology: a new diagnostic endpoint? Source: Virtual Congress 2020 – Chronic cough: only symptom or disease? Year: 2020 A new diagnostic method for aspirin-sensivity: lysine-aspirin intravenous challenge Source: Eur Respir J 2002; 20: Suppl. 38, 424s Year: 2002 Mannitol challenge test Source: Procedure Video 2015 Year: 2015 Mannitol challenge testing in clinical practice and its role in identifying aiways hyperreactivity Source: Annual Congress 2012 - Lung function tests in monitoring airway diseases Year: 2012 ERS technical standard on bronchial challenge testing: pathophysiology and methodology of indirect airway challenge testing Source: Eur Respir J, 52 (5) 1801033; 10.1183/13993003.01033-2018 Year: 2018 ERS technical standard on bronchial challenge testing: pathophysiology and methodology of indirect airway challenge testing Source: Eur Respir J 2018; 52: 1801033 Year: 2018 Improving the appropriate use of Mannitol challenge testing in a large teaching hospital. Source: Virtual Congress 2021 – Lung function testing in the management of obstructive diseases Year: 2021 Modern molecular direct tests for rapid identification and drug susceptibility testing of Mycobacterium tuberculosis Source: Annual Congress 2012 - Microbiological advances in the diagnosis of tuberculosis Year: 2012 Bedaquiline: 10?years later, the drug susceptibility testing protocol is still pending Source: Eur Respir J 2015; 45: 317-321 Year: 2015 Mannitol dry powder challenge in comparison with exercise testing and methacholine challenge test in children Source: Annual Congress 2008 - Assessment of inflammation, hyperresponsiveness and response to exercise in asthmatic children Year: 2008 Improved diagnostics and diagnostic approaches: The role in the fight to emerging infectious diseases (EID) and antimicrobial resistance (AMR) Source: Postgraduate course 2021: PG7 - Postgraduate course : Emerging infectious diseases and antimicrobial resistance: diagnostics, treatments, vaccines and other preventive and/or therapeutic interventions Year: 2021 From the bedside: upcoming new clinical strategies: novel strategies to combat respiratory viral infections Source: International Congress 2017 – Scientific year in review Year: 2017 Tuberculosis: update on new diagnostic methods and treatment approach Source: Annual Congress 2007 - Infections year in review Year: 2007 Early evening session: The new drug discovery paradigm Source: Lung Science Conference 2014 - Lung Inflammation and Immunity Year: 2014 When will genetic testing replace standard drug susceptibility testing? Source: International Congress 2018 – Important changes in the management of tuberculosis Year: 2018 COVID-19 conundrum: clinical phenotyping based on pathophysiology as a promising approach to guide therapy in a novel illness Source: Eur Respir J, 56 (2) 2002135; 10.1183/13993003.02135-2020 Year: 2020 Conditional expanding post-exposure prophylaxis: a potential new tool for tuberculosis control Source: ERJ Open Res, 7 (1) 00723-2020; 10.1183/23120541.00723-2020 Year: 2021